$ACRS reloaded again $1.42 now holding 6500 shares..ESKATA Canadian regulatory approval coming..which will bring in upfront payments and drug royalties from Cipher Pharmaceuticals (Canadian commercial partner)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.